ENTELLUS MED INC's ticker is ENTL and the CUSIP is 29363K105. A total of 52 filers reported holding ENTELLUS MED INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $494,000 | +136.4% | 20,257 | +78.8% | 0.00% | – |
| Q3 2017 | $209,000 | +95.3% | 11,329 | +74.7% | 0.00% | – |
| Q2 2017 | $107,000 | +18.9% | 6,483 | -1.5% | 0.00% | – |
| Q1 2017 | $90,000 | -98.8% | 6,583 | -98.3% | 0.00% | -100.0% |
| Q4 2016 | $7,200,000 | -17.7% | 379,535 | -3.8% | 0.00% | 0.0% |
| Q3 2016 | $8,749,000 | -3.6% | 394,436 | -20.6% | 0.00% | -25.0% |
| Q2 2016 | $9,074,000 | +0.2% | 496,665 | -0.3% | 0.00% | 0.0% |
| Q1 2016 | $9,057,000 | +15.6% | 497,929 | +7.2% | 0.00% | +33.3% |
| Q4 2015 | $7,832,000 | +0.3% | 464,550 | +7.2% | 0.00% | 0.0% |
| Q3 2015 | $7,811,000 | +20.9% | 433,468 | +73.5% | 0.00% | +50.0% |
| Q2 2015 | $6,463,000 | -40.9% | 249,836 | -50.0% | 0.00% | 0.0% |
| Q1 2015 | $10,940,000 | – | 499,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,956,456 | $48,960,000 | 52.70% |
| Discovery Group I, LLC | 2,169,729 | $35,931,000 | 10.38% |
| Essex Woodlands Management, Inc. | 3,231,656 | $53,516,000 | 9.68% |
| Archon Capital Management LLC | 478,820 | $7,929,000 | 6.46% |
| First Light Asset Management, LLC | 512,416 | $8,486,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 341,468 | $5,655,000 | 2.15% |
| Ghost Tree Capital, LLC | 375,000 | $6,210,000 | 1.29% |
| PERKINS CAPITAL MANAGEMENT INC | 68,316 | $1,131,000 | 1.25% |
| Cypress Capital Management LLC (WY) | 63,540 | $1,052,222,000 | 1.21% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 35,000 | $580,000 | 0.66% |